July 9 (Reuters) - Benitec Biopharma Ltd BLT.AX :
* Acquisition of hepatitis B program
* Acquires full rights to pre-clinical hepatitis B (HBV) program from Biomics Biotechnologies
* In addition, Biomics will receive a single-digit royalty on net sales once the product is marketed
* Under terms of agreement, co will pay biomics A$2.5 million upfront with A$3.5 million upon successful commercialization of program
* Source text for Eikon ID:nASX9Kmb1V